Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis
- PMID: 9199462
- PMCID: PMC175404
- DOI: 10.1128/iai.65.7.2876-2882.1997
Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis
Abstract
A murine model of pneumonia due to the mouse pneumonitis agent (MoPn [murine Chlamydia trachomatis]) in mice deficient in CD4+ T-cell function (major histocompatibility complex [MHC] class II function [class II-/-], CD8+ T-cell function (beta2-microglobulin deficient, MHC class I deficient [Beta2m-/-]), B-cell function (C57BL/10J-Igh(tm1Cgn) [Igh-/-]), and gamma interferon (IFN-gamma) (C57BL/6-Ifg(tm1) [Ifg-/-]) or interleukin-4 (C57BL/6J(tm1Cgn29) [IL4-/-]) production was employed to determine if each of these mechanisms was critical to resistance against reinfection by C. trachomatis or if alternate compensatory mechanisms existed in their absence which could potentially be exploited in vaccine development. Resistance to reinfection with MoPn was heavily dependent on CD4+ T cells. CD4 T-cell-deficient MHC class II-/- mice were very susceptible to reinfection with MoPn, showing the critical importance of this cell to resistance. These mice lacked antibody production but did produce IFN-gamma, apparently by mechanisms involving NK and CD8+ T cells. Neutralization of IFN-gamma in these mice led to a borderline increase in susceptibility, showing a possible role (albeit small) of this cytokine in this setting. Tumor necrosis factor alpha (TNF-alpha) was also present at increased levels in these mice. Igh-/- B-cell-deficient mice which produce no antibody to MoPn were only modestly more susceptible to reinfection than immunized B-cell-intact controls, showing that antibody, including lung immunoglobulin A, is not an absolute requirement for relatively successful host defense in this setting. Levels of lung IFN-gamma and TNF-alpha were elevated in Igh-/- mice compared to those in controls. IL-4-/- mice (deficient in Th2 function) could develop normal resistance to reinfection with MoPn. Conversely, normal mice rendered partially IFN-gamma deficient by antibody depletion were somewhat impaired in their ability to develop acquired immunity to MoPn, again indicating a role for this cytokine in host defense against rechallenge. Of most importance, however, congenitally IFN-gamma-deficient Ifg-/- mice (which have elevated levels of other cytokines, including TNF-alpha and granulocyte-macrophage colony-stimulating factor) are paradoxically more resistant to MoPn rechallenge than controls, showing that IFN-gamma is not an absolute requirement for acquired resistance and implying the presence of very effective compensatory host defense mechanism(s). In vivo depletion of TNF-alpha significantly increased MoPn levels in the lungs in these mice. Thus, resistance to reinfection in this model is flexible and multifactorial and is heavily dependent on CD4+ T cells, with a probable role for IFN-gamma and TNF-alpha and a possible modest role for Th1-dependent antibody. Since IFN-gamma was dispensable in host defense, the highly effective mechanism or mechanisms which can compensate for its absence (which include TNF-alpha) deserve further study.
Similar articles
-
Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.Mol Med. 2000 Jul;6(7):604-12. Mol Med. 2000. PMID: 10997341 Free PMC article.
-
Gamma interferon levels during Chlamydia trachomatis pneumonia in mice.Infect Immun. 1993 Aug;61(8):3556-8. doi: 10.1128/iai.61.8.3556-3558.1993. Infect Immun. 1993. PMID: 8335389 Free PMC article.
-
Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition.J Immunol. 1999 Mar 15;162(6):3541-8. J Immunol. 1999. PMID: 10092812
-
Insights into innate immune cell evasion by Chlamydia trachomatis.Front Immunol. 2024 Jan 25;15:1289644. doi: 10.3389/fimmu.2024.1289644. eCollection 2024. Front Immunol. 2024. PMID: 38333214 Free PMC article. Review.
-
Protozoa: Pathogenesis and Defenses.In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 78. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 78. PMID: 21413293 Free Books & Documents. Review.
Cited by
-
CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa.Mucosal Immunol. 2011 Mar;4(2):208-16. doi: 10.1038/mi.2010.58. Epub 2010 Sep 15. Mucosal Immunol. 2011. PMID: 20844481 Free PMC article.
-
The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells.Cell Immunol. 2006 Aug;242(2):110-7. doi: 10.1016/j.cellimm.2006.10.002. Epub 2006 Nov 20. Cell Immunol. 2006. PMID: 17116296 Free PMC article.
-
Host immune responses to chlamydial inclusion membrane proteins B and C in Chlamydia trachomatis infected women with or without fertility disorders.Reprod Biol Endocrinol. 2009 Apr 28;7:38. doi: 10.1186/1477-7827-7-38. Reprod Biol Endocrinol. 2009. PMID: 19397832 Free PMC article.
-
Host-Cell Survival and Death During Chlamydia Infection.Curr Immunol Rev. 2007;3(1):31-40. doi: 10.2174/157339507779802179. Curr Immunol Rev. 2007. PMID: 18843378 Free PMC article.
-
NK Cells Contribute to Protective Memory T Cell Mediated Immunity to Chlamydia muridarum Infection.Front Cell Infect Microbiol. 2020 Jun 17;10:296. doi: 10.3389/fcimb.2020.00296. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32626664 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials